4.5 Article

A Guide for a Cardiovascular Genomics Biorepository: the CATHGEN Experience

期刊

出版社

SPRINGER
DOI: 10.1007/s12265-015-9648-y

关键词

Cardiovascular disease; Genetics; Genomics; Metabolomics; Air pollution; Geocoding; Biorepository; Biomarkers; Cardiometabolic disease

资金

  1. BG Medicine, Inc.
  2. CardioDx, Inc.
  3. Qiagen, Inc.
  4. Liposcience, Inc..
  5. US Environmental Protection Agency
  6. NIH [HL101621, HL095987]

向作者/读者索取更多资源

The CATHeterization GENetics (CATHGEN) biorepository was assembled in four phases. First, project start-up began in 2000. Second, between 2001 and 2010, we collected clinical data and biological samples from 9334 individuals undergoing cardiac catheterization. Samples were matched at the individual level to clinical data collected at the time of catheterization and stored in the Duke Databank for Cardiovascular Diseases (DDCD). Clinical data included the following: subject demographics (birth date, race, gender, etc.); cardiometabolic history including symptoms; coronary anatomy and cardiac function at catheterization; and fasting chemistry data. Third, as part of the DDCD regular follow-up protocol, yearly evaluations included interim information: vital status (verified via National Death Index search and supplemented by Social Security Death Index search), myocardial infarction (MI), stroke, rehospitalization, coronary revascularization procedures, medication use, and lifestyle habits including smoking. Fourth, samples were used to generate molecular data. CATHGEN offers the opportunity to discover biomarkers and explore mechanisms of cardiovascular disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据